Package | ihe.qrph.qore |
Resource Type | Measure |
Id | example-IHE-QORE-Opioid-11 |
FHIR Version | R4 |
Source | http://profiles.ihe.net/QRPH/QORE/https://build.fhir.org/ig/IHE/QRPH.QORE/Measure-example-IHE-QORE-Opioid-11.html |
URL | http://profiles.ihe.net/QRPH/QORE/Measure/example-IHE-QORE-Opioid-11 |
Version | 0.1.0 |
Status | unknown |
Date | 2024-10-23T20:00:04+00:00 |
Title | Percentage of suspected opioid OD patients experiencing who exhibit adverse effects after naloxone administration |
Realm | uv |
Authority | ihe |
Copyright | IHE http://www.ihe.net/Governance/#Intellectual_Property |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: Measure example-IHE-QORE-Opioid-11
version: 0.1.0
title: Percentage of suspected opioid OD patients experiencing who exhibit adverse effects after naloxone administration
status: Unknown
date: 2024-10-23 20:00:04+0000
publisher: IHE Quality, Research and Public Health Committee
contact: https://www.ihe.net/ihe_domains/quality_research_and_public_health/, qrph@ihe.net, IHE Quality, Research and Public Health Committee: qrph@ihe.net
jurisdiction: Global (Whole world)
copyright:
IHE http://www.ihe.net/Governance/#Intellectual_Property
type: outcome
rationale:
Patients an opioid overdose may become agitated or violent following naloxone administration due to acute opioid withdrawal. Therefore, the goal is to use the lowest dose possible to restore spontaneous respirations but avoid precipitating withdrawal
definition:
Measures the percentage of suspected opioid OD patients experiencing who exhibit adverse effects after naloxone administration.
group
population
code: numerator
description: All patients who were given Narcan, and developed adverse effects.
Criteria
Language CQL population
code: denominator
description: All patients who were given Narcan.
Criteria
Language CQL
{ "resourceType": "Measure", "id": "example-IHE-QORE-Opioid-11", "meta": { "security": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ActReason", "code": "HTEST" } ] }, "text": { "status": "generated", "div": "<!-- snip (see above) -->" }, "url": "http://profiles.ihe.net/QRPH/QORE/Measure/example-IHE-QORE-Opioid-11", "version": "0.1.0", "title": "Percentage of suspected opioid OD patients experiencing who exhibit adverse effects after naloxone administration", "status": "unknown", "date": "2024-10-23T20:00:04+00:00", "publisher": "IHE Quality, Research and Public Health Committee", "contact": [ { "telecom": [ { "system": "url", "value": "https://www.ihe.net/ihe_domains/quality_research_and_public_health/" } ] }, { "telecom": [ { "system": "email", "value": "qrph@ihe.net" } ] }, { "name": "IHE Quality, Research and Public Health Committee", "telecom": [ { "system": "email", "value": "qrph@ihe.net" } ] } ], "jurisdiction": [ { "coding": [ { "system": "http://unstats.un.org/unsd/methods/m49/m49.htm", "code": "001" } ] } ], "copyright": "IHE http://www.ihe.net/Governance/#Intellectual_Property", "type": [ { "coding": [ { "code": "outcome" } ] } ], "rationale": "Patients an opioid overdose may become agitated or violent following naloxone administration due to acute opioid withdrawal. Therefore, the goal is to use the lowest dose possible to restore spontaneous respirations but avoid precipitating withdrawal", "definition": [ "Measures the percentage of suspected opioid OD patients experiencing who exhibit adverse effects after naloxone administration." ], "group": [ { "population": [ { "code": { "coding": [ { "code": "numerator" } ] }, "description": "All patients who were given Narcan, and developed adverse effects.", "criteria": { "language": "text/cql" } }, { "code": { "coding": [ { "code": "denominator" } ] }, "description": "All patients who were given Narcan.", "criteria": { "language": "text/cql" } } ] } ] }